Finance

Lists
Why is OKYO up 11,36%?
Dive Deeper
OKYO:NASDAQ
OKYO Pharma Ltd
USD 1,47
+11,36%
(+0,15) 1D
USD 1,45
-1,36% (-0,020)
After hours
Closed: 2 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
USD 1,33
High
USD 1,47
Low
USD 1,33
Mkt. cap
77,14 m
Avg. vol.
72,53 k
Volume
82,52 k
52-wk high
USD 3,20
52-wk low
USD 1,26
EPS
-USD 0,32
Beta
-0,03
Shares outstanding
52,48 m
No. of employees
5
Open
USD 1,33
High
USD 1,47
Low
USD 1,33
Mkt. cap
77,14 m
Avg. vol.
72,53 k
Volume
82,52 k
52-wk high
USD 3,20
52-wk low
USD 1,26
EPS
-USD 0,32
Beta
-0,03
Shares outstanding
52,48 m
No. of employees
5
News stories
From web sources and news partners
About OKYO Pharma Ltd
CEO-
Employees5
Founded2007
Headquarters-
Sector-
Websiteokyopharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current USD 1,47
USD 7,00 (+376,19%)
Average
USD 6,00 (+308,16%)
Lowest
USD 5,00 (+240,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Biren Amin
Piper Sandler
Buy
Maintained
USD 7,00
+376,2%
08/27/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
USD 5,00
+240,1%
07/13/2026
William Wood
B. Riley Securities
Buy
Initiated
USD 5,00
+240,1%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
1,27 m
1,27 m
2,07 m
2,07 m
Cost of revenue
1,27 m
1,27 m
2,07 m
2,07 m
Research and development expenses
-22,02 k
-22,02 k
926,55 k
926,55 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-22,02 k
-22,02 k
926,55 k
926,55 k
Total operating expenses
1,25 m
1,25 m
3,00 m
3,00 m
Operating income
-1,25 m
-1,25 m
-3,00 m
-3,00 m
Other non operating income
-
-
-140,00
-140,00
EBT including unusual items
-1,29 m
-1,29 m
-3,18 m
-3,18 m
EBT excluding unusual items
-1,29 m
-1,29 m
-3,18 m
-3,18 m
Income tax expense
26,00
26,00
3,97 k
3,97 k
Effective tax rate
-
-
-0,12%
-0,12%
Other operating expenses
-
-
-
-
Net income
-1,29 m
-1,29 m
-3,18 m
-3,18 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
16,05 k
16,05 k
Interest expense
-42,29 k
-42,29 k
-194,68 k
-194,68 k
Net interest expenses
-42,29 k
-42,29 k
-178,63 k
-178,63 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,25 m
-1,25 m
-3,00 m
-3,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme